Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis

Zeshen Wu1,2,3, Yulu Peng1,2,3, Longbin Xiong1,2,3

  • 1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Cancer Medicine
|April 27, 2022
PubMed

Insights

Sam68 protein levels influence treatment outcomes for metastatic renal cell carcinoma (RCC). Higher Sam68 expression enhances sunitinib-induced apoptosis, suggesting it may predict patient response to this targeted therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Sunitinib is a first-line targeted therapy for metastatic renal cell carcinoma (RCC), acting via antiangiogenesis and proapoptosis.
  • Sam68 (Src-associated in mitosis, 68 KDa) is implicated in cellular apoptosis pathways.

Purpose of the Study:

  • To investigate the role of Sam68 in mediating RCC cell apoptosis and its impact on sunitinib sensitivity.
  • To determine if Sam68 expression levels can serve as a predictive biomarker for sunitinib efficacy in ccRCC patients.

Main Methods:

  • Immunohistochemical staining of tumor tissues to compare Sam68 expression in sunitinib-sensitive versus resistant RCC.
  • In vitro experiments assessing sunitinib-induced apoptosis and Sam68 expression (total and phosphorylated) in RCC cells.
  • In vivo studies using xenograft models with Sam68-knockdown and control groups treated with sunitinib.

Main Results:

  • Sam68 expression was significantly higher in sunitinib-sensitive RCC tissues compared to resistant tissues.
  • Sunitinib induced RCC cell apoptosis in a dose-dependent manner, concurrently inhibiting Sam68 expression.
  • Downregulating Sam68 reduced sunitinib-induced apoptosis, while upregulating Sam68 enhanced it. Xenograft tumors in Sam68-knockdown mice showed less shrinkage with sunitinib treatment.

Conclusions:

  • Sam68 expression is correlated with ccRCC patient sensitivity to sunitinib.
  • Sam68 promotes sunitinib-induced apoptosis in RCC cells.
  • Sam68 levels may serve as a predictive biomarker for sunitinib response in ccRCC.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K